News

board write 게시판
Title G.M.C. Starts Amyloid PET testing for Alzheimer"s Disease Diagnosis
Date 2016.05.19 Link

- First to run clinical trials using Flutemetamol since October, 2015-
- Flutemetamol, precisely shows depositions of Amyloid in color –

Gachon University Gil Medical Center has started up ‘Flutemetamol Amyloid (PET-CT) tests that increases the precision for the diagnosis of Amyloid protein, which deposits in the brain of patients suffering from dementia.

There are many causes for dementia. Although they might be the same dementia due to degenerative brain disease, there are diverse options for treatment and prognosis depending on its type. Alzheimer’s disease is the most common brain disease that causes dementia, and over 70% of the entire patients with dementia have Alzheimer’s disease.

Alzheimer’s disease is caused due to excess deposition of B-Amyloid protein in the brain. Conventional PET scans in the past could only show brain image in black and white for the diagnosis of Alzheimer’s disease.

Gachon University Gil Medical Center is now able to carry out Amyloid PET tests using radioactive chemical, Flutemetamol (F-18 FMM) to look for the existence and deposition of the Amyloid protein. Flutemetamol is the only FDA approved, color coding.

Gachon University Gil Medical Center became the first one to carry out Flutemetalmol PET examination last October 2015, using PET in Gachon University Neuroscience Research Institute, for the purpose of clinical research. Since then, they have carried out PET tests for over 100 cases, currently having the most diagnosis experience in the country.

Gachon University Gil Medical Center has launched “Gachon Brain Health Center” to specialize in diagnosis, treating and for the maintenance of patients suffering from dementia and different brain diseases in February, 2016.

Rho Young, a doctor in neurology at Gachon University Gil Medical Center said, “Since the newly introduced method allows us to precisely detect deposition of Amyloid protein in the brain, it is thus extremely useful for early diagnosis of Aldzheimer’s along with differential diagnosis of other types of dementia.”

*Attachment: Amyloid PET brain scan picture